Atlas Trials

Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Clinical trial NCT07054086 · RECRUITING

Trial details

NCT number
NCT07054086
Sponsor
Shanghai Zhongshan Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Esophageal Cancer
Start date
2025-03-01
Primary completion
2026-02-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.